Fluroxypyr Human Health and Ecological Risk Assessment FINAL REPORT
Total Page:16
File Type:pdf, Size:1020Kb
SERA TR-052-13-03a Fluroxypyr Human Health and Ecological Risk Assessment FINAL REPORT Submitted to: Paul Mistretta, COR USDA/Forest Service, Southern Region 1720 Peachtree RD, NW Atlanta, Georgia 30309 USDA Forest Service Contract: AG-3187-C-06-0010 USDA Forest Order Number: AG-43ZP-D-07-0013 SERA Internal Task No. 52-13 Submitted by: Patrick R. Durkin Syracuse Environmental Research Associates, Inc. 5100 Highbridge St., 42C Fayetteville, New York 13066-0950 Fax: (315) 637-0445 E-Mail: [email protected] Home Page: www.sera-inc.com June 12, 2009 Table of Contents LIST OF FIGURES ........................................................................................................................ v LIST OF TABLES.......................................................................................................................... v ATTACHMENT............................................................................................................................. v LIST OF APPENDICES................................................................................................................ vi ACRONYMS, ABBREVIATIONS, AND SYMBOLS ............................................................... vii COMMON UNIT CONVERSIONS AND ABBREVIATIONS................................................... ix CONVERSION OF SCIENTIFIC NOTATION ............................................................................ x EXECUTIVE SUMMARY ........................................................................................................... xi 1. INTRODUCTION ..................................................................................................................... 1 2. PROGRAM DESCRIPTION..................................................................................................... 4 2.1. OVERVIEW ........................................................................................................................ 4 2.2. CHEMICAL DESCRIPTION AND COMMERCIAL FORMULATIONS........................ 4 2.3. APPLICATION METHODS............................................................................................... 6 2.4. MIXING AND APPLICATION RATES ............................................................................ 7 2.5. USE STATISTICS............................................................................................................... 8 3. HUMAN HEALTH RISK ASSESSMENT................................................................................ 9 3.1. HAZARD IDENTIFICATION.......................................................................................... 9 3.1.1. Overview....................................................................................................................... 9 3.1.2. Mechanism of Action.................................................................................................. 10 3.1.3. Pharmacokinetics and Metabolism ............................................................................. 10 3.1.3.1. General Considerations........................................................................................ 11 3.1.3.2. Absorption............................................................................................................ 12 3.1.3.3. Excretion.............................................................................................................. 14 3.1.4. Acute Oral Toxicity .................................................................................................... 16 3.1.5. Subchronic or Chronic Systemic Toxic Effects.......................................................... 17 3.1.6. Effects on Nervous System......................................................................................... 20 3.1.7. Effects on Immune System ......................................................................................... 21 3.1.8. Effects on Endocrine System...................................................................................... 21 3.1.9. Reproductive and Developmental Effects .................................................................. 23 3.1.9.1. Developmental Studies ........................................................................................ 23 3.1.9.2. Reproduction Studies........................................................................................... 23 3.1.10. Carcinogenicity and Mutagenicity............................................................................ 24 3.1.11. Irritation and Sensitization (Effects on the Skin and Eyes) ...................................... 25 3.1.11.1. Skin Irritation..................................................................................................... 25 3.1.11.2. Skin Sensitization............................................................................................... 25 3.1.11.3. Ocular Effects .................................................................................................... 25 3.1.12. Systemic Toxic Effects from Dermal Exposure ....................................................... 25 3.1.13. Inhalation Exposure .................................................................................................. 26 3.1.14. Inerts and Adjuvants ................................................................................................. 27 3.1.14.1. Inerts .............................................................................................................. 27 3.1.14.2. Adjuvants ....................................................................................................... 28 3.1.15. Impurities and Metabolites ....................................................................................... 28 ii 3.1.15.1. Metabolites......................................................................................................... 28 3.1.15.2. Impurities ........................................................................................................... 29 3.1.16. Toxicological Interactions ........................................................................................ 29 3.2. EXPOSURE ASSESSMENT .......................................................................................... 30 3.2.1. Overview..................................................................................................................... 30 3.2.2. Workers....................................................................................................................... 30 3.2.2.1. General Exposures ............................................................................................... 31 3.2.2.2. Accidental Exposures........................................................................................... 32 3.2.3. General Public........................................................................................................... 33 3.2.3.1.1. Likelihood and Magnitude of Exposure ....................................................... 33 3.2.3.1.2. Summary of Assessments ............................................................................. 34 3.2.3.2. Direct Spray ......................................................................................................... 34 3.2.3.3. Dermal Exposure from Contaminated Vegetation............................................... 35 3.2.3.4. Contaminated Water ............................................................................................ 36 3.2.3.4.1. Accidental Spill............................................................................................. 36 3.2.3.4.2. Accidental Direct Spray/drift for a Pond or Stream...................................... 37 3.2.3.4.3. GLEAMS Modeling...................................................................................... 37 3.2.3.4.4. Other Modeling Efforts................................................................................. 38 3.2.3.4.5. Monitoring Data............................................................................................ 38 3.2.3.4.6. Concentrations in Water Used for Risk Assessment .................................... 39 3.2.3.5. Oral Exposure from Contaminated Fish .............................................................. 40 3.2.3.6. Dermal Exposure from Swimming in Contaminated Water................................ 42 3.2.3.6. Oral Exposure from Contaminated Vegetation.................................................... 43 3.3. DOSE-RESPONSE ASSESSMENT ................................................................................. 45 3.3.1. Overview..................................................................................................................... 45 3.3.2. Acute RfD ................................................................................................................... 45 3.3.3. Chronic RfD................................................................................................................ 46 3.3.4. Surrogate RfD for Occupational Exposures ............................................................... 46 3.3.5. Dose-Severity Relationships....................................................................................... 47 3.4. RISK CHARACTERIZATION....................................................................................... 49 3.4.1. Overview..................................................................................................................... 49 3.4.2. Workers......................................................................................................................